Lung Cancer

ASCO23 – WU-KONG6 Trial Summary

Author: Lei Deng, MD Roswell Park Comprehensive Cancer Center   Live report from ASCO23, Chicago, IL June 6, 2023  …

1 year ago

My Take On KEYNOTE-671: ASCO23 June 3, 2023

Author:  Lei Deng, MD PGY-6 Fellow of Hematology/Oncology - Roswell Park Comprehensive Cancer Center, Buffalo, NY.  Incoming Assistant Professor at UW/Fred Hutch,…

1 year ago

AEGEAN trial: A phase 3 study of Neoadjuvant Durvalumab plus Chemotherapy followed by Adjuvant Durvalumab versus Neoadjuvant Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer

By Dr. Dipesh Uprety Karmanos Cancer Institute   Four cycles of cisplatin-based adjuvant chemotherapy after surgical resection have remained the…

2 years ago

CheckMate-722: Nivolumab plus Chemotherapy versus Chemotherapy in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer with Disease Progression after EGFR Tyrosine Kinase Inhibitors

By Dr. Dipesh Uprety Karmanos Cancer Institute   While immunotherapy is being used religiously for non-oncogene-addicted advanced non-small cell lung…

2 years ago

2022 Updates in Lung Cancer Treatment

By Dr. Kanak Parmar Texas Tech University   Perioperative systemic therapy for resectable non-small cell lung cancer Surgical resection followed…

2 years ago

De-escalating Therapy in Human Papillomavirus-Related Oropharyngeal Cancer

By Dr. Tarik Hadid Wayne State University   Human papillomavirus (HPV) is a small DS-DNA virus, and humans are the…

2 years ago